MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
17.96
-0.07 (-0.39%)
Mar 5, 2026, 4:00 PM EST - Market closed
MapLight Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MapLight Therapeutics stock have an average target of 31, with a low estimate of 28 and a high estimate of 34. The average target predicts an increase of 72.61% from the current stock price of 17.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 21, 2025.
Analyst Ratings
The average analyst rating for MapLight Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +55.90% | Nov 21, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +78.17% | Nov 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $30 | Buy | Initiates | $30 | +67.04% | Nov 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $34 | Buy | Initiates | $34 | +89.31% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.48
from -105.38
EPS Next Year
-3.77
from -6.48
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.68 | -2.92 | |
| Avg | -6.48 | -3.77 | |
| Low | -9.75 | -4.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.